research News

Trieste, Italy – An international study, coordinated by the University of Trieste in collaboration with the Azienda Sanitaria Universitaria Giuliano Isontina and the National Amyloidosis Centre in London, may revolutionize early treatment approaches for transthyretin cardiac amyloidosis. This rare and progressive heart disease is caused by the abnormal accumulation of...
Barcelona, Spain – An international team of scientists led by ICREA researcher and Director of the Life Sciences Department at the Barcelona Supercomputing Centre – Centro Nacional de Supercomputación (BSC-CNS), Alfonso Valencia, has developed a technology based on artificial intelligence (AI) for the study of orphan diseases and has successfully...
BUFFALO, NY- February 12, 2024 – A new research paper was published in Oncotarget’s Volume 15 entitled, “Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples.” Raw areca nut (AN) consumption increases esophageal squamous cell...
Lancaster, England – The genetic disease Huntington’s not only affects nerve cells in the brain but also has widespread effects on microscopic blood vessels according to research. These changes to the vasculature were also observed in the pre-symptomatic stages of the disease, demonstrating the potential for this research for predicting...
Tel Aviv, Israel – In a breakthrough study an international team of scientists led by researchers from Tel Aviv and Glasgow Universities, the ‘cat parasite’ Toxoplasma gondii was engineered to deliver drugs to the human brain. The study was led by Prof. Oded Rechavi from the Department of Neurobiology and...
Nashville, Tennessee – Vanderbilt University Medical Center (VUMC) researchers are touting data from a multicenter, international phase 2 clinical trial showing a new, curative treatment for sickle cell disease (SCD). The therapy, nonmyeloablative haploidentical bone marrow transplant (BMT) with thiotepa and posttransplant cyclophosphamide (PTCy), is proving to have equivalent efficacy...